IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i13p8063-d852877.html
   My bibliography  Save this article

The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence

Author

Listed:
  • Iordanis Mourouzis

    (Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Ave., Goudi, 11527 Athens, Greece
    These authors contributed equally to this work.)

  • Vassiliki Apostolaki

    (Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Ave., Goudi, 11527 Athens, Greece
    These authors contributed equally to this work.)

  • Athanasios Trikas

    (Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Ave., Goudi, 11527 Athens, Greece)

  • Leonidas Kokkinos

    (Department of Anesthesiology, ELPIS General Hospital of Athens, 11522 Athens, Greece)

  • Natassa Alexandrou

    (Department of Anesthesiology, ELPIS General Hospital of Athens, 11522 Athens, Greece)

  • Maria Avdikou

    (Department of Anesthesiology, ELPIS General Hospital of Athens, 11522 Athens, Greece)

  • Myrto Giannoulopoulou

    (Department of Anesthesiology, ELPIS General Hospital of Athens, 11522 Athens, Greece)

  • Aimilia Vassi

    (Department of Anesthesiology, ELPIS General Hospital of Athens, 11522 Athens, Greece)

  • Ioulia Tseti

    (Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Ave., Goudi, 11527 Athens, Greece)

  • Constantinos Pantos

    (Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Ave., Goudi, 11527 Athens, Greece)

Abstract

Tissue hypoxia is one of the main pathophysiologic mechanisms in sepsis and particularly in COVID-19. Microvascular dysfunction, endothelialitis and alterations in red blood cell hemorheology are all implicated in severe COVID-19 hypoxia and multiorgan dysfunction. Tissue hypoxia results in tissue injury and remodeling with re-emergence of fetal programming via hypoxia-inducible factor-1α (HIF-1a)-dependent and -independent pathways. In this context, thyroid hormone (TH), a critical regulator of organ maturation, may be of relevance in preventing fetal-like hypoxia-induced remodeling in COVID-19 sepsis. Acute triiodothyronine (T3) treatment can prevent cardiac remodeling and improve recovery of function in clinical settings of hypoxic injury as acute myocardial infarction and by-pass cardiac surgery. Furthermore, T3 administration prevents tissue hypoxia in experimental sepsis. On the basis of this evidence, the use of T3 treatment was proposed for ICU (Intensive Care Unit) COVID-19 patients (Thy-Support, NCT04348513). The rationale for T3 therapy in severe COVID-19 and preliminary experimental and clinical evidence are discussed in this review.

Suggested Citation

  • Iordanis Mourouzis & Vassiliki Apostolaki & Athanasios Trikas & Leonidas Kokkinos & Natassa Alexandrou & Maria Avdikou & Myrto Giannoulopoulou & Aimilia Vassi & Ioulia Tseti & Constantinos Pantos, 2022. "The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence," IJERPH, MDPI, vol. 19(13), pages 1-13, June.
  • Handle: RePEc:gam:jijerp:v:19:y:2022:i:13:p:8063-:d:852877
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/13/8063/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/19/13/8063/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:13:p:8063-:d:852877. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.